Method for using synthetic analogs of thrombospondin for inhibit

Details Method for using synthetic analogs of thrombospondin for inhibit Method for using synthetic analogs of thrombospondin for inhibit

1995-03-22

1996-04-09

Warden, Jill

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 16, 530327, 530329, A61K 3800, C07K 700, C07K 706, C07K 512

Patent

active

055062083

ABSTRACT:
Methods of use of compounds and compositions comprising fragments and synthetic analogs of human thrombospondin are provided for promoting or inhibiting thrombospondin-like activity.

REFERENCES:
patent: 5190918 (1993-03-01), Deutch et al.
patent: 5192744 (1993-03-01), Bouck et al.
patent: 5200397 (1993-04-01), Deutch et al.
Tuszynski, et al, J. Biol Chem, 262, pp. 9718-9723, 1987.
Henessy, et al. J. of Cell Biol. 168, pp. 729-736 1989.
Tuszynski, et al. Cancer Research, 47, 4130-33, 1987.
Riser, et al, Experimental Cell Research 174 pp. 319-329, 1988.

Affiliated with

Also associated with

Rating

Method for using synthetic analogs of thrombospondin for inhibit does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for using synthetic analogs of thrombospondin for inhibit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for using synthetic analogs of thrombospondin for inhibit will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-138979